Search Results
Search results for "Tack Kuntz"
Results found for "Tack Kuntz"
- Discovery of 3(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligand
predicted that all the compounds showed the critical salt bridge with Glu172 with variable degrees of Ď-stacking
- Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...
Perkins' Molecular Endocrinology and Pharmacology Laboratory team who are investigating new ways to tackle
- Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...
diseases, but few therapies have been directed against GPCRs in the field of cancer, partly because of the lack
- Focusing on the role of secretin/adhesion (Class B) G protein-coupled receptors in placental...
Effective methods to treat preeclampsia are lacking, and termination of pregnancy remains the only curative
- GPCR Drug Discovery Summit 2026: What to Expect in Boston â and How to Register
A panel discussion will tackle best practices for measuring GPCR signaling bias in vitro and what that
- GPCR Happy Hour Boston 2026 â April 29 | Dr. GPCR Community Event
They happen in the hallway between sessions, at the coffee station, or in the ten minutes after a talk It's the size where you can actually talk to everyone in the room. Where you walk away with a handful of connections that actually go somewhere, not a stack of business Their deorphanisation track record (17 identified natural receptor-ligand pairs) speaks to the depth
- GPCR Happy Hour â Boston, Sept 2025
The panels are packed. Everyoneâs rushing from one talk to the next. But the truth?
- PAR-Induced Harnessing of EZH2 to β-Catenin: Implications for Colorectal Cancer
physiological and disease functions, yet knowledge of their role in colon cancer stem cell maintenance is still lacking
- Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research
However, researchers faced a challenge with the target C5aR , as they lacked the appropriate tools to However, there is a notable lack of fluorescent probes available in the market for this receptor.
- Reflections on My PhD Journey: Lessons Learned
Procrastination may seem tempting, but tackling your work incrementally will save time and reduce stress
- Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026
After a brief pause over the holidays and last month, weâre back in full forceâdesigned to help you make
- Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and...
in endothelial cells, which was evidenced by the attenuation of organ fibrosis in mice specifically lacking
- GRK2 in cardiovascular disease and its potential as a therapeutic target
Currently-approved treatments have improved patient outcomes, but therapies to stop or reverse HF are lacking
- From Pipettes to Platforms: The Evolution of GPCR Research
The Era of Cold Fingers and Patience Back then, GPCR signaling experiments werenât elegant; they were
- How GPCR Spatial Signaling Sparked a Scientific Journey
It was supposed to be just a summer projectâroutine pipetting, repetitive assays, a box to tick before Many GPCR scientists trace their origin story back to a single unexpected spark. Not a grand plan.
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
extracellular N-termini by 31 amino acids, but detailed insights into their functional differences are lacking
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
This technique can acquire three-dimensional image stacks, facilitating the reconstruction of GPCR distribution If the experiment is done on live cells , tracking real-time receptor internalization becomes possible
- GPCRs at Discovery on Target 2026
His talk digs into the molecular basis of partial agonism at the mu opioid receptor, using mitragynine It is a timely look at how receptor pharmacology can sharpen one of the most talked-about therapeutic At Discovery on Target she is giving a talk on an NMR fragment screen against an orphan GPCR, describing Stepping into the GPCR track at Discovery on Target is part of that work. Inside the GPCR Track This Year The GPCR content is concentrated on Wednesday, September 30, and it spans
- How Schild Analysis Protects Your Conclusions in GPCR Research
Welcome back GPCR Fans, Clean data can still mislead if the underlying assumptions arenât tested.
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
With this high-resolution, dynamic view of GPCR activation, scientists can better tackle diseases by
- Fluorescence Polarization in GPCR Research
We highlight this article by Tahk et al. Â
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Welcome back GPCR fans, If your drug discovery strategy still relies on static GPCR models, youâre already
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
stall not because the target is wrongâbut because the chemical matter  interacting with that target lacks
- Predicting GPCR Function: Inside the Carlsson Labâs Modeling Toolbox
To tackle these, the lab employs molecular docking, molecular dynamics simulations, and ligand-based
- Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5...
quantification of SST2/SST5 dimerization in rat GH3 as well as in human melanoma cells either expressing (A7) or lacking
- The Five Traps of Ignoring Kinetics
And once you see it, youâll never go back.
- Curve Shifts Donât Lie, But Your Eyes Might
And once you make that shift, youâll never go back.
- Understanding the Journey: Catherine Demery's Path to Addiction Science
It was mostly just because, I need to be back in the lab.â
- Amylin Receptor Signaling: Three Receptors From One, and How to Profile Each
β-arrestin readouts, the subtypes that matter for weight loss, and ortholog assays that tie bench data back
- Targeted Activation of G-Protein Coupled Receptor-Mediated Ca 2+ Signaling Drives Enhanced Cartilage
or pharmacological activation of endogenous Ca2+ signaling transducers; however, such approaches can lack




















